We have qualitatively reviewed American Century Mid Cap Value and reaffirmed its Process and People ratings. The team’s strong leader and process remain in place, and his team has been steady. One-year returns (through Sept. 30, 2023), while disappointing, have not been out of character, as growth gains left this defensive strategy out of favor. The following text is from Oct. 31, 2022.
American Century Mid Cap Value R5 AMVGX
- NAV / 1-Day Return 16.86 / −0.82 %
- Total Assets 8.5 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.780%
- Distribution Fee Level Average
- Share Class Type Retirement, Large
- Category Mid-Cap Value
- Investment Style Mid Value
- Min. Initial Investment 0
- Status Open
- TTM Yield 1.66%
- Turnover 54%
USD | NAV as of Oct 07, 2024 | 1-Day Return as of Oct 07, 2024, 10:40 PM GMT+0
Morningstar’s Analysis AMVGX
Will AMVGX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Zimmer Biomet Holdings Inc | 3.03 | 249.7 Mil | Healthcare |
Bank of New York Mellon Corp | 2.24 | 184.9 Mil | Financial Services |
Conagra Brands Inc | 2.14 | 176.3 Mil | Consumer Defensive |
Enterprise Products Partners LP | 2.00 | 165.3 Mil | Energy |
Koninklijke Ahold Delhaize NV | 1.90 | 156.6 Mil | Consumer Defensive |
Northern Trust Corp | 1.89 | 156.3 Mil | Financial Services |
Henry Schein Inc | 1.89 | 156.3 Mil | Healthcare |
Willis Towers Watson PLC | 1.89 | 156.0 Mil | Financial Services |
Quest Diagnostics Inc | 1.85 | 152.7 Mil | Healthcare |
Edison International | 1.85 | 152.2 Mil | Utilities |